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 Abstract  
A central assumption is that lipid transfer proteins (LTPs) bind transiently to organelle membranes to 
distribute lipids in the eukaryotic cell. Osh6p and Osh7p are yeast LTPs that transfer 
phosphatidylserine (PS) from the endoplasmic reticulum (ER) to the plasma membrane (PM) via 
PS/phosphatidylinositol-4-phosphate (PI4P) exchange cycles. It is unknown how, at each cycle, they 
escape from the electrostatic attraction of the PM, highly anionic, to return to the ER. Using cellular 
and in vitro approaches, we show that Osh6p reduces its avidity for anionic membranes once it 
captures PS or PI4P, due to a molecular lid closing its lipid-binding pocket. Thus, Osh6p maintains its 
transport activity between ER- and PM-like membranes. Further investigations reveal that the lid 
governs the membrane docking and activity of Osh6p because it is anionic. Our study unveils how an 
LTP self-limits its residency time on membranes, via an electrostatic switching mechanism, to transfer 
lipids efficiently. 
 Introduction 
Lipids are accurately distributed in the eukaryotic cell to confer to organelles their physical 
features and molecular identity
1,2
. Phosphatidylserine (PS), representing 2-10% of total membrane 
lipids
3-6
, is a negatively-charged glycerophospholipid that is spread along a gradient in the cell. Its 
concentration increases between the ER, where it accounts for 5-7% of glycerophospholipids, and the 
PM where its proportion can rises up to 30%
7-9
. It mostly accumulates in the cytosolic leaflet of this 
membrane. This build-up and asymmetric distribution of PS in the PM are critical for signalling 
pathways, mediated by cytosolic proteins that are recruited and/or activated by this lipid
9
. Like other 
lipids predominantly found in the PM
10-13
, PS is synthesized in the ER
14
, meaning that it must be 
exported to the PM. How this is accomplished was unknown
9
 until the demonstration that in 
Saccharomyces cerevisiae, Osh6p and its homologue Osh7p mediate ER-to-PM PS transport
15
.  
Osh6p and Osh7p belong to the oxysterol-binding protein-related proteins (ORPs)/oxysterol-
binding homologue(Osh) family which is a major group of lipid transfer proteins (LTPs) and/or lipid 
sensors in eukaryotes
16
. All members of this family have a domain – called ORD (OxySterol Binding 
Protein (OSBP)-Related Domain) – to encapsulate specific lipid species. A few of them, including 
Osh6p and Osh7p, consist only of an ORD, whereas others contain additional modules
16
. The ORD of 
Osh6p/Osh7p has a cavity to host one PS molecule; this pocket is closed by an N-terminal lid that 
shields the lipid from the aqueous environment
17
. Remarkably, Osh6p can alternately trap 
phosphatidylinositol-4-phosphate (PI4P)
18
.  PI4P is made at the PM, as well as in other compartments 
of the secretory pathway, and is hydrolysed into phosphatidylinositol at the ER
19
. Thus a PI4P gradient 
exists at the ER/PM interface and Osh6p/Osh7p use this gradient to transfer PS from the ER to the PM 
by PS/PI4P exchange cycles. During each cycle, they would extract a PS molecule from the ER, 
exchange it for PI4P at the PM, and deliver PI4P to the ER where PI4P is hydrolyzed
18
. In human, 
ORP5/ORP8 act similarly at ER-PM contact sites 
20
.  Several ORP/Osh proteins likely use PI4P 
gradients to move other lipids, as demonstrated for Osh4p or OSBP, which are sterol/PI4P 
exchangers
21
. 
Due to the abundance of PS, the cytosolic side of the PM is highly negatively-charged 
compared to that of other organelles
9,22,23
. This generates high electrostatic forces that are exploited by 
signalling proteins targeting this region : MARCKS
24
, Src
25
,  K-Ras
26
 or Rac1
27
 bind to the PM via a 
stretch of positively-charged amino-acids and a lipidic tail ; conventional PKC
28
 recognizes PS using a 
C2 domain. These binding reactions are regulated: MARCK or K-Ras are displaced from the PM 
through phosphorylation 
26,29
, whereas the binding of the PKC C2 domain depends on Ca
2+
  levels 
28
. 
What about Osh6p and Osh7p?  During one PS/PI4P exchange cycle, they must interact with the PM 
and then escape from the electrostatic field of the PM to return to the ER, whose surface is less 
anionic
1,8,9,22
.It is often implicitly assumed that LTPs must bind transiently to donor and acceptor 
organelle membranes to be efficient
30-33
. Because structural analyses suggest that several LTPs change 
 their conformation when encapsulating a ligand
17,34,35
, it is also often speculated that the status of an 
LTP, empty or loaded, influences its membrane-binding capacities
17,33
. This has been demonstrated for 
the phosphatidylinositol transfer protein PITPα 36 whose exchange dynamics depend on its ability to 
undergo a conformational change upon capturing lipid. Apart from this example, the dynamic changes 
during transport reactions are poorly documented. Furthermore, there are many examples of LTPs 
(Sec14p, nsLTP, GLTP) whose activity is impeded in the presence of negatively-charged membranes 
due to their high retention on such membranes
37-39
. How can Osh6p/Osh7p work efficiently at the 
ER/PM interface?  
Here, we address this issue via cellular observations combined to in vitro and in silico 
analyses. We find that Osh6p has a reduced binding to anionic membranes, once it extracts PS or 
PI4P, because its N-terminal lid closes. Consequently, Osh6p maintains a fast transport activity 
between membranes resembling the ER-membrane and PM. Molecular dynamics (MD) simulations 
suggest that the attraction forces between the closed form of Osh6p and membranes are weak, because 
the lid is anionic and masks some membrane-interacting regions. Charge-neutralizing mutations in a 
aspartate(D)/glutamate(E)-rich motif in the lid impair Osh6p’s activity. We demonstrate that a LTP 
uses an electrostatic switching mechanism to self-limit its residency time on membranes and thereby, 
be efficient.  
 
  
 Results 
Osh6p firmly binds to membranes if its lid region is mutated 
When Osh6p is chromosomally tagged with GFP, it can be observed in patches at the cell cortex, 
confirming its enrichment at ER-PM contact sites
15,40
. In addition, diffuse fluorescence throughout the 
cell suggests a significant soluble pool of Osh6-GFP (Fig.1a). Similar localization is observed when 
Osh6p-GFP is expressed from a CEN plasmid under the control of the pADH1 promotor in an 
osh6Δosh7Δ strain in the case of weakly expressing cells (Fig.1b). In contrast, cells with higher 
fluorescent levels, likely harboring multiple copies of the plasmid, display only cytoplasmic 
fluorescence, suggesting that there are a limited number of Osh6p-binding sites at the cortical ER. We 
next compared localization of Osh6p (termed WT), fused to mCherry, to that of two mutants, L69D 
and H157A/H158A (thereafter called HH/AA), which are deficient for PS transport
18
. Osh6p(L69D), 
in which an anionic residue replaces an hydrophobic one in the lid (Fig.1c), cannot bind or trap PS
15
. 
Osh6p(HH/AA) does not recognize PI4P and is therefore unable to convey PS via PS/PI4P 
exchange
18
. Despite their similar defects in PS transport, these mutants have different intracellular 
distribution (Fig.1d): Osh6p(HH/AA) is cytosolic and enriched at the cortex like Osh6p, whereas 
Osh6p(L69D) is less cytosolic and instead bound to membranes in highly-expressing cells. Notably, it 
colocalizes with the ER-marker Sec63p, but is also seen in other intracellular structures and enriched 
at the cell surface (Fig. 1d and Supplementary Figure 1a). Besides, some bright internal spots may 
represent Osh6p(L69D) aggregates (Fig.1d). The localization of a deletion mutant Osh6pΔ69 that 
lacks the lid (residues 36 to 69) and an upstream low-complexity region [1-35], is similar to that of 
Osh6p(L69D) (Fig.1d and Supplementary Figure 1a). This mutant does not transfer PS in vitro
18
 or in 
cells (Supplementary Figure 1b). Thus, a mutation within the lid, or the deletion of the N-terminal 
region that includes the lid, increases the propensity of Osh6p to interact with membranes.  
We next analyzed the membrane-binding capacity of Osh6p in vitro by measuring its 
association with neutral or anionic liposomes in flotation assays. Recombinant wild-type protein was 
mixed with liposomes made of 1,2-dioleoyl-sn-glycero-3-phosphocholine (DOPC) and increasing 
levels (0, 5, 10 or 30% mol/mol) of 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphoserine (POPS). These 
liposomes were then recovered from the top of a sucrose gradient following centrifugation, and the 
percentage of Osh6p bound to liposomes was quantified. Osh6p has a low avidity for membranes; less 
than 15% of protein was recruited onto liposomes irrespective of their PS density (Fig.1e). We then 
evaluated how Δ69, L69D and HH/AA mutants interacted with membranes containing 30% PS, or 
additionally 4% PI4P, compared to Osh6p (WT).  Remarkably, Δ69 and L69D mutants have a high 
avidity for these membranes (~75% of bound protein, Fig.1f) whereas Osh6p (HH/AA) remained 
mostly soluble, like Osh6p. The fraction of membrane-bound Osh6pΔ69 and Osh6p(L69D) increases 
with the density of PS in the liposomes, contrary to Osh6p (Fig.1g), suggesting that electrostatic forces 
 drive the interaction of these mutants with membranes. We conclude that the increased localization of 
L69D and Δ69 mutants to cellular membranes might be due to their stronger avidity for lipid bilayers. 
 
High membrane-binding Osh6p’s mutants do not extract lipids  
 To explain these data, we looked for functional differences between Osh6p and its mutants, first by  
quantifying their ability to remove PS from liposomes using a PS-sensor NBD-C2Lact
41
. This sensor 
bears an NBD fluorophore whose emission intensity depends on whether it is bound or not to 
membrane. When incubated with liposomes containing 2% POPS, the fluorescence of NBD-C2Lact was 
high (Fig.2a), indicating that it was membrane-bound. In the presence of Osh6p, the fluorescence was 
low and comparable to that measured with PS-free liposomes. This indicated, after signal 
normalization, that 75-80% of accessible PS was extracted (Fig.2b). Osh6p(HH/AA) exhibited a similar 
extraction efficiency. In contrast, Osh6pΔ69 and Osh6p(L69D) did not provoke any substantial 
dissociation of the probe, indicative of their inability to extract PS. A related assay based on a PI4P-
sensor, NBD-PHFAPP, revealed that Δ69, L69D and HH/AA mutants fail to extract PI4P (Fig.2c,d, <20% 
extraction), contrary to Osh6p (100%). Jointly these data indicated that Osh6pΔ69 and Osh6p(L69D) 
extract neither PS nor PI4P, whereas Osh6p(HH/AA) is still able to encapsulate PS. We conclude that 
the higher avidity of Osh6pΔ69 and Osh6p(L69D) for membranes, in yeast or in vitro, might be 
because they remain empty, although these membranes contain PS and PI4P.  
 
 
Osh6p strongly binds to anionic membranes as its lid is open 
Osh6pΔ69 remains empty probably because, without a lid, it cannot secure PS or PI4P inside its pocket, 
as suggested by previous structural and in silico analyses
15,18
. For the L69D mutant, we assumed that it 
behaved like Osh6pΔ69 because its lid was unable to close. To investigate this point, we devised an 
assay for evaluating the conformational state of Osh6p. We purified an Osh6p(noC/S190C) construct 
including a single cysteine at position 190, predicted to be solvent-exposed only if the lid is open 
(Fig.3a). This protein was mixed with 7-diethylamino-3-(4'-maleimidylphenyl)-4-methylcoumarin 
(CPM), which becomes fluorescent when forming a covalent bond with a thiol group. After a 30-min 
incubation with the protein alone in buffer, we measured a high fluorescence indicative of the 
accessibility of the cysteine. This suggested that Osh6p could regularly adopt an open state 
(Supplementary Figure 2a,b). A higher signal was obtained when Osh6p(noC/S190C) was mixed with 
pure DOPC liposomes, indicating that the protein was more frequently open in that context (Fig.3a, 
Supplementary Figure 2b). In contrast, when Osh6p(noC/S190C) was added to liposomes with 2% 
POPS or PI4P, we recorded an extremely low signal, suggesting that the protein, in the presence of its 
ligands, remained essentially closed. 
We repeated these measurements with an Osh6p(noC/S190C) construct bearing the L69D 
mutation. We measured in solution a CPM signal similar to that obtained with the previous construct 
 and obtained higher signals with liposomes, but even if they contained PS or PI4P. This was not due to 
a denaturation process since the two noC/S190C constructs are properly folded (Supplementary Figure 
2c). We conclude that the L-to-D substitution prevents the lid from closing in the presence of a ligand 
and that the L69D mutant binds more to PS and PI4P-containing membranes because it corresponds to 
a constitutively open form of Osh6p. 
Therefore, we hypothesized that the affinity of Osh6p for membranes was dependant on its 
conformational state. To investigate this, we performed assays with Osh6p and liposomes 
incorporating diphytanoyl-PS instead of POPS. Diphytanoyl-PS is a synthetic PS species whose C16:0 
acyl-chains bear branched methyl groups (Fig.3b). Consequently, it would be too bulky to be 
accommodated by Osh6p. Our PS-extraction assay confirmed this, showing no change in the signal of 
NBD-C2Lact when Osh6p was mixed with liposomes containing 2% diphytanoyl-PS (Fig.3c). We 
mixed Osh6p(noC/S190C) with these liposomes and found using our CPM assay that the protein was 
unable to properly close because the final CPM intensity was similar to that measured with DOPC 
liposomes and much higher than in the presence of membranes with POPS (Fig.3d). In flotation 
assays, Osh6p weakly bound to neutral membranes exclusively made of DOPC or containing 30% 
diphytanoyl-PC, or to anionic membranes with 30% POPS (< 25% of membrane-bound protein).  In 
contrast, it tightly associated with anionic liposomes with 30% diphytanoyl-PS (72.6 ± 3.1%). We 
confirmed this using a second assay and a fluorescent Osh6p in which a unique cysteine (C262) within 
the β14-β15 loop, is labeled with NBD (Supplementary Figure 3a-c). Adding DOPC/diphytanoyl-PS 
(70/30 mol/mol) liposomes to NBD-Osh6p elicited a blue-shift of its fluorescence with an increase in 
intensity, indicative of its recruitment onto membrane (Fig.3f). In contrast, no change was seen with 
liposomes solely made of DOPC or enriched with 30% diphytanoyl-PC or POPS.  Last, we found that 
Osh6p strongly bound to liposomes enriched with other anionic lipids, either 30% phosphatidic acid 
(PA) or phosphatidylinositol (PI) (Supplementary Figure 4a). They are not ligands for Osh6p as, 
unlike PS, they do not prevent the protein from extracting PI4P (Supplementary Figure 4b) when they 
are in excess in the same membrane. We conclude that Osh6p binds in a non-specific electrostatic 
manner to anionic membranes, if they are devoid of extractable lipid, because it remains empty and 
open. 
 
Osh6p dissociates from membranes upon trapping its ligands 
Our data suggested that Osh6p loses its ability to associate with a membrane once it extracts a 
lipid ligand and closes. To explore this, we first examined whether the lid was the sole structural 
element of the N-terminus of Osh6p to mediate this process. We purified a Δ35 deletion mutant, 
devoid of the low-complexity region upstream of the lid, and found that it behaves similarly as Osh6p. 
First, it efficiently extracts PS or PI4P, except if it bears the L69D mutation (Fig.4a). Second, 
compared to Δ69 and L69D mutants, it weakly interacts with anionic membranes containing PS or 
both PS and PI4P (Fig.4b, Supplementary Figure 4c). Third, fluorescence assays showed that a 
 Osh6pΔ35 construct, labeled with NBD, binds to diphytanoyl-PS-rich membranes but not neutral or 
POPS-rich membranes (Fig.4c). This suggests that in the N-terminal region of Osh6p, the lid is the 
unique element that guarantees the extraction efficiency of the protein and controls its membrane-
binding properties.  
 Then, we examined in real-time whether the membrane-binding capacity of Osh6p changed in 
the presence of a ligand. Osh6p or the Δ35 mutant, labeled with NBD, was mixed with liposomes 
containing 30% diphytanoyl-PS, resulting in a maximal NBD signal, indicative of their association to 
membranes. The addition of short-chained PS (di-C12:0) stored in methanol provoked a fast decrease 
in fluorescence, whereas pure methanol did not (Fig.4d). This effect was specific to Osh6p since no 
drop in signal was seen when adding PS to NBD-C2Lact bound to diphytanoyl-PS-rich liposomes. 
Thus, Osh6p dissociates from an anionic membrane once an extractable lipid is available. 
To quantify this, we performed flotation assays by incubating Osh6p or Osh6pΔ35 with 
liposomes containing 70% DOPC and 30% diphytanoyl-PS, and no or increasing amount of POPS (2, 
5 or 10%, Fig.4e). Remarkably, whereas these proteins efficiently bind to membranes devoid of POPS, 
they bind two-time less to membranes doped with 2% POPS and are essentially soluble at higher 
POPS concentration (Fig.4e). Comparable results were obtained with diphytanoyl-PS-rich liposomes 
doped with PI4P, yet at a lesser extent with Osh6p. In contrast, Osh6p(L69D) and Osh6pΔ35(L69D) 
remained attached, whatever the POPS or PI4P level.  Last, Osh6p and Osh6pΔ35 associate with 
anionic liposomes rich in PA or PI but, overall, less if these liposomes contain 5% PS or PI4P 
(Supplementary Figure 4d). Jointly, these data suggest that trace amounts of ligand reduce the 
retention of Osh6p on anionic membranes, if its lid is functional. 
 
Osh6p retains its solubility and activity as it can close 
We further explored whether the low affinity of the lipid-loaded form of Osh6p for 
membranes might be important for its exchange activity at the ER/PM interface. To this end, we tested 
the ability of Osh6p, Osh6p35 or Osh6p69 to transport PI4P from LB (PM-like) liposomes doped 
with 5% PI4P and Rhodamine-phosphatidylethanolamine (Rhod-PE), to LA liposomes (ER-like) 
containing 5% PS, under conditions where PS/PI4P exchange occur
18
. Two conditions were tested for 
each protein: with LB liposomes incorporating 25% diphytanoyl-PC or 25% diphytanoyl-PS, thus 
either weakly or highly anionic. In each measurement, the PI4P-sensor NBD-PHFAPP 
41
 was pre-mixed 
with LB liposomes: it associates with these vesicles resulting in the quenching of the NBD signal by 
FRET to Rhod-PE. Then, LA liposomes and an Osh6p variant were injected (Fig. 5a). With weakly 
anionic LB liposomes, the addition of Osh6p or Osh6p35 provoked a fast fluorescence dequenching, 
corresponding to the transfer of PI4P from LB to LA membranes. Based on normalized signals, PI4P is 
rapidly equilibrated between liposomes. The initial transport rates for Osh6p and its 35 counterpart 
were 31.2 ± 4 and 30.2 ± 1.8 PI4P.min
-1
 per protein, respectively (mean ± s.e.m., Fig. 5b). Osh6p69 
 transports PI4P to some extent, despite the absence of the lid (3.3 ± 1.2 PI4P.min
-1
), as found 
previously
18
. With very anionic LB liposomes, Osh6p WT and 35 remained efficient as PI4P was 
almost completely transferred within 2 min. The transport rate was reduced by ~70% with Osh6p but 
only by ~30% with Osh6p35. In comparison, the activity of Osh6p69 was abrogated.  In view of 
our binding measurements, we conclude that Osh6p and Osh6p35, contrary to Osh6p69, might 
minimize their retention onto anionic LB liposomes owing to the lid and the presence of PI4P. 
Consequently, they can efficiently shuttle PI4P to LA liposomes in the context of PS/PI4P exchange.  
We then investigated whether Osh6p or Osh6pΔ35 remained soluble during transport by 
measuring to what extent their NBD-labeled forms bound to LA and LB liposomes, respectively doped 
with 5% PS and 5% PI4P (as in the transport assays), or not.  With LB liposomes containing 25% 
diphytanoyl-PC, each protein remained mostly in solution regardless of the presence or absence of 
ligand, as we observed only a slight increase in NBD fluorescence above its minimal value in the two 
cases (Fig.5c). In comparison, a major difference was seen with LB liposomes rich in diphytanoyl-PS. 
If PS and PI4P were present, proteins were weakly membrane-bound, as previously seen. In contrast, 
if both ligands were absent, proteins were fully bound, as indicated by a high signal, which became 
noisy due to liposomes aggregation. We conclude that, when lipid ligands are present, Osh6p remains 
free to circulate between membranes to exchange them. 
 
The lid is anionic and weakens the membrane binding of Osh6p 
We next examined how the lid, when closing, could change the membrane-binding ability of 
Osh6p. Looking at the Osh6p structure, which corresponds to Osh6pΔ3515, we identified a motif, rich 
in aspartate and glutamate at the N-terminal end of the lid. Analyses of ORP/Osh sequences with a PS-
recognizing motif LPTFILE
15
 indicated that the D/E-rich stretch is conserved in Osh6p and Osh7p 
homologues (Supplementary Figure 5), but also in ORP9, -10 and -11, suggesting a functional role. A 
comparison of the electrostatic potential surface of Osh6pΔ35, in complex with PS, and that of 
Osh6pΔ69, in a ligand-free state, revealed that the lid exposes a negative surface (Fig.6a) and hides a 
positively-charged area around the entry of the lipid-binding pocket. Thus, the closing of the lid might 
modulate the avidity of Osh6p for membrane by altering the electrostatic features of its surface. 
To explore this possibility, we analyzed by MD simulations how Osh6p35 or 69 docked onto 
an anionic membrane made of 70% DOPC and 30% POPS (4 simulations of 500 ns per protein, 
Supplementary Movie 1 to 4). Each construct was placed, with diverse initial orientations, ~54 Å away 
from the membrane plane (Supplementary Figure 6a). Root-Mean-Square-Deviation calculation and 
secondary structure analysis showed that Osh6p remained folded during all trajectories except at the 
end of Δ69-4 trajectory (the C-terminal part of Osh6pΔ69 displaced from the core structure, 
Supplementary Figure 6b, 7). In each Osh6p variant, the N and C-termini, several loops and the 7- 
helix are slightly mobile, as indicated by the Root-Mean-Square Fluctuations per residue; in 
 Osh6pΔ35, the lid displayed some motions (Supplementary Figure 6c). Key differences where found 
when analyzing how Osh6pΔ35 and Δ69 bound to the membrane. In all trajectories, Osh6pΔ69 
associates with the membrane, as reflected over time by a shorter height (h) of its center of mass 
relative to the membrane plane (shortest h = 16.1 Å, Fig.6b). In contrast, Osh6pΔ35 binds to the 
membrane during two trajectories (Δ35-1 and -4, shortest h = 29 Å) but remains in solution during the 
two others (Δ35-2 and -3, h ≥ 41.7 Å).  Calculating Coulomb and VDW interaction energy between 
each protein and the membrane revealed a major role of electrostatic attraction in the binding process 
(Supplementary Figure 8). Remarkably, the Coulomb and VDW interaction between Osh6pΔ69 and 
the membrane were more than twice stronger (lowest E=-2,454 and -687 kcal.mol
-1
, respectively) 
compared to Osh6pΔ35 (lowest E=-1,173 and -352 kcal.mol-1). These results support the idea that 
Osh6p is more prone to bind to a membrane when its lid is open.  
Osh6pΔ35 and Δ69 are differently positioned on the membrane at the end of simulations, as 
indicated by the angle measured between the α7-helix of  the protein and the normal to the membrane 
plane (Fig.6b). To better analyze this, we counted during trajectories how many times each of their 
residues was less than 5 Å away from lipid headgroups, considering there was a contact with 
membrane below this threshold. Osh6pΔ35 docks onto the membrane via residues of the β17-β18 loop 
and, transiently, of the β14-β15 loop (Fig.6c,d; Supplementary Figure 9a) during a short period (244-
365 ns) of the Δ35-1 trajectory (Supplementary Movie 1). The entry of the pocket remains far from the 
membrane (shortest hentry=20.22 Å, Supplementary Figure 9c). For Osh6pΔ69, the β11-β12 and β14-
β15 loops systematically make contacts with the membrane during a significant time fraction of each 
simulation (f =25-50%). During the Δ69-1, -2 and -3 trajectories, the β7-β8, β16-β17 and β17-β18 
loops and 18-sheet also frequently insert between lipids (Fig.6c,d). In the fourth trajectory, 
Osh6pΔ69 adopts another docking geometry, due to a combined insertion of strands (β7, 8) and loops 
(7-8, β11-β12, β14-β15) in the membrane (Supplementary Figure 9b). At the end of all simulations, 
the entry of the pocket is near to the bilayer surface (shortest hentry = 4.38 Å, Supplementary Figure 
9c). Interestingly, during the Δ69-4 trajectory, the entry is in the membrane plane, (hentry between -0.55 
and 1 Å), thus in a configuration maybe compatible with an extraction process (Supplementary Figure 
9b,c).  
The difference in accessible surface area between Δ35 and Δ69 structures indicates that part of the 
lid covers the β7 sheet and β11-β12 loop, which can anchor Osh6pΔ69 in the bilayer (Supplementary 
Figure 9d). If Osh6pΔ35 was positioned on membrane surface like Osh6pΔ69, the lid would insert 
between the lipids (Supplementary Figure 9e), which is unlikely as it is anionic. This suggests that the 
lid  forbids some docking modes. We examined this by performing a simulation in which Osh6pΔ35 
was already anchored to the membrane (final configuration of Δ35-1 trajectory) but from which the lid 
was deleted. Remarkably, it comes closer to the membrane plane while changing its orientation 
(Fig.7a-c), and adopts a configuration akin to that of Osh6pΔ69 at the end of Δ69-1, 2 and 3 
trajectories, as indicated by the analysis of the last 100 ns of each simulation (Fig.7c,d). In summary, 
 our simulations suggest that the lid, when closing, prevents Osh6p from interacting with membrane 
because it is anionic and masks some membrane-binding regions.   
 
Osh6p loses its activity if its lid is less anionic  
We then analyzed to what extent the D/E-rich motif in the lid might play a role in Osh6p’s 
activity. To this end, we purified two mutants, Osh6p-4A and Osh6p-5A2G, in which respectively four 
or seven aspartate and glutamate residues within this motif were substituted by alanine or glycine for 
neutralizing anionic charges (Fig.8a). Electrostatic potential calculations show that in the 4A and 
5A2G structures, compared to the native one, part of the lid exposes a positively-charged surface 
whose area increases with the number of substitutions (Fig.8b). Both mutants significantly extracted 
PS or PI4P from liposomes, suggesting that the lid was functional (Fig.8c). Flotation assays indicated 
that they interacted more with membrane containing 30% PS and 4% PI4P than Osh6p, suggestive of a 
tendency to remain adsorbed onto anionic membranes despite the presence of ligands (Fig.8d). Next, 
we measured using ER-like (LA) and PM-like (LB) liposomes how the negative charge of membranes 
affects the activity of these mutants, compared to Osh6p (Fig.8e). The rate of PI4P transfer mediated 
by 4A and 5A2G mutants is divided by ~7 and 22, respectively, when LB liposomes contain 25% 
diphytanoyl-PS instead of diphytanoyl-PC, more than for Osh6p (~3, Fig.8f). We obtained similar 
results (Fig.8f) with LA and LB liposomes that additionally contained PI and PA to better mimic the 
ER-membrane and the PM
8
. We tested the functionality of the more strongly affected 5A2G mutant in 
yeast. First we examined how it supported growth of a strain lacking all seven OSH genes and only 
expressing a temperature-sensitive allele of osh4. These cells cannot survive at the non-permissive 
temperature of 37C, but grow at 25C, where the osh4-1ts allele is functional42. The growth at 37C 
was rescued by expression of Osh6p (Fig.8g), likely as it substitutes for Osh4p to remove PI4P from 
post-Golgi vesicles and thereby restore exocytosis
43
. We also confirmed that the L69D and HH/AA 
mutants fail to restore growth
43
, possibly as they cannot extract and transport PI4P (Fig.1g and
18
). In 
contrast, the 5A2G as well as the Δ35 and Δ69 mutants rescue growth. Corroborating in vitro data, this 
suggests that in yeast Osh6p-5A2G recognizes PI4P, like the deletion mutants. However, whereas 
Osh6p transfers PS from the ER to the cell surface (Fig.8h and 
15,18
), the expression of Osh6p-5A2G 
produces an intermediate phenotype: some PS reaches the surface and some remains at the ER during 
the time-course (Fig.8h). All these data suggest that attenuating the anionic nature of the lid limits 
Osh6p in its capacity to escape from negatively-charged membranes and to displace lipids.   
  
 Discussion  
 Deciphering the mode of action of LTPs, at the core of lipid distribution, is an important issue 
in cell biology
1,2
. Many models implicitly assume that LTPs bind transiently to organelles to quickly 
transfer lipids
30,32,33
, yet almost nothing is known about these association/dissociation steps. We found 
that Osh6p, a PS/PI4P exchanger of the ORP/Osh family, has no propensity to associate with the lipid 
surface of the ER and the PM and a weak avidity for neutral or negatively-charged liposomes in vitro. 
In contrast, Osh6p strongly associates with yeast membranes, including the ER, and with anionic 
liposomes, if the lid that controls the entry of its lipid-binding pocket is absent or unable to close. It also 
binds to anionic membranes if they are devoid of extractable ligands, PS or PI4P. If these lipids are 
available, Osh6p dissociates because its lid closes upon lipid extraction. These data supports the idea 
that the occupancy of a LTP by its ligand can modulate its conformational state and therefore its 
membrane-binding capacity
17,33
. Interestingly, this resembles to the mechanism that controls the 
recruitment of small G-proteins onto membranes depending on their ligand status (GDP or GTP-
bound)
44,45
. Using a model system mimicking the ER/PM interface, we established that a high density of 
anionic lipids in PM-like membrane weakly impacts the transport activity of Osh6p and its Δ35 
counterpart, because both have a functional lid. During this process, they remain largely soluble. The lid 
is thus a structural element that allows Osh6p to stay very briefly on the membrane, and thereby to 
ensure lipid exchange, regardless of the density of anionic lipids. 
To understand why, we performed in silico analyses on the structure of Osh6p, i.e. Osh6pΔ3515 , 
and of the lidless Osh6pΔ69, taking into account several points. First, Osh6pΔ35 behaves like Osh6p : 
the 1-35 region upstream of the lid plays no role in the coupling between lipid extraction and 
membrane dissociation. Second, Osh6pΔ69 is equivalent to Osh6p(L69D), thus to a constitutively 
open form of Osh6p. Third, modeling a structure of Osh6p with an open lid was problematic. These 
analyses indicated that the lid is anionic, due to a D/E-rich motif, and that it changes the electrostatic 
features of Osh6p’s surface when closed. In MD simulations, Osh6p35 binds less to an anionic 
membrane than Osh6pΔ69, due to weaker non-covalent interactions. Osh6p35 inserts in the bilayer 
via its β17-β18 loop and, sometimes, its β14-β15 loop. Interestingly, a corresponding loop seems 
critical for anchoring Osh4p to membrane
46
. In comparison, the insertion of Osh6p69 relies on these 
loops but also on extra regions, including a positively-charged surface surrounding the entry of the 
pocket that is exposed when the lid is absent. This entry can localize at the water/membrane interface, 
suggesting that Osh6p, once open, adopts a configuration compatible with an extraction/delivery 
process. Finally we showed that charge-neutralizing mutations of the D/E-rich motif increase the 
ability of Osh6p to bind to anionic membranes and can lower its transfer activity in vitro and at the 
ER/PM interface.  
We propose that the lid supports an electrostatic switching mechanism that helps Osh6p to 
transiently associate with the ER and the PM. Thus Osh6p can freely circulate between these 
 compartments to ensure continuous lipid exchange. This would explain why a large fraction of this 
LTP is cytosolic at steady-state and why the L69D and Δ69 mutants, with no functional lid and a 
higher propensity to interact with anionic surfaces, display an increased localization to intracellular 
membranes. The precision in PS/PI4P exchange mediated by Osh6p can be therefore assured by 
continuous PS synthesis at the ER and the maintenance of a PI4P gradient at the ER/PM interface
18
. 
Presumably, additional factors contribute to the targeting of Osh6-mediated lipid transport, including 
protein-protein interactions. However, the accuracy of transport likely does not rely on the ability of 
Osh6p to differentially bind organelle surfaces according to their bulk lipid composition.  When its 
ligands are present, the avidity of Osh6p for membranes and its activity remain largely insensitive to 
the density (up to 45%) and nature of anionic lipids.  Nevertheless, the 1-35 region, upstream of the 
lid, might have targeting properties. We noted subtle differences between Osh6p and Osh6pΔ35 in 
vitro: Osh6p keeps some avidity for anionic membranes containing PI4P and its PI4P transport activity 
is slightly more sensitive to the presence of anionic lipids, compared to Osh6pΔ35. The 1-35 region, 
with a net charge of +4, might allow Osh6p to target phosphoinositides; unfolded positively-charged 
motifs, used by proteins like MARCK to interact with anionic bilayers, can recognize PI(4,5)P2
47
.  
 It is unknown whether other ORP/Osh proteins utilize a switching mechanism like Osh6p. The 
membrane-binding capacity of Osh6p depends on whether or not the lid occludes a basic surface at the 
entry of the binding pocket, which is well-conserved among ORP/Osh proteins.  One might speculate 
that in Osh4p, whose lid has no D/E-rich motif 
17,48
, this occlusion alone modulates its association with 
the ER and Golgi/post-Golgi membranes, which are less anionic than the PM and between which this 
protein operates
49-51
. ORP5 and ORP8 are PS/PI4P exchangers at ER-PM contact sites
20
, but their ORDs 
have no D/E-rich motifs (Supplementary Figure 4), in contrast to ORP10, which exchange PS and PI4P  
at ER-Golgi contacts
52
. These proteins are more complex as they reside in the ER and bind to the Golgi 
or PM via a PH domain
20
. Possibly, in that configuration, the ORD targets sequentially the membranes 
through weak interactions and a D/E-rich motif is not critical. In contrast, Osh6p is unique among the 
PS/PI4P exchangers because its ORD must both target membrane and exchange lipids. Consequently, 
the anionic nature of the lid would be necessary to break the interaction of the ORD with the membrane, 
once lipids are exchanged. This might be even critical in a cellular context. Indeed, if Osh6p remains 
empty, it aggregates membranes. This is partially reminiscent of a previous study showing that Osh6p 
strongly bound to and aggregated liposomes although they contained PS
40
. However, in this study, the 
liposomes were not representative of cellular membranes because they were very anionic (50-100% 
DOPS) with a loose lipid packing; likely, these combined features artificially promoted protein-
membrane interactions
22
. Interestingly, like Osh6p, the membrane-binding capacity of PITPα, a member 
of a distinct LTP family, depends on whether or not it hosts its ligands
36
. It is possible that several 
ORP/Osh proteins and many other types of LTPs have a switching mechanism whose nature remains to 
be defined.  
 Methods  
Protein expression and purification  
Osh6p was cloned in pGEX-4T-3 vector to code for a GST-fused construct
18
. The different 
site-specific mutations or deletion in Osh6p were obtained by the Quikchange kit (Agilent). The 
oligonucleotides are listed in the Supplementary Table 1. For the truncated [70-448]Osh6p mutant 
(Osh6pΔ69), a short GGGG linker was introduced between the protein and GST to facilitate the 
cleavage by thrombin
18
.  To build the Osh6p noC/S190S, the sequence of the protein was mutated to 
replace three endogenous cysteine residues (C62, C162, C389) by serine and to substitute a serine 
located under the lid by a cysteine (S190C mutation). To prepare NBD-labeled Osh6p WT and NBD-
labeled Osh6pΔ35, the endogenous cysteines were replaced by serines and a cysteine was introduced 
into the β14-β15 loop by mutating a threonine (T262C substitution). To build the mutant Osh6p-4DA, 
four anionic residues in Osh6p WT (D38, D39, D41 and E42) were replaced each by an alanine 
residue.  In Osh6p-5A2G, three additional mutations were performed (D43G, D44G, E45A). Glycine 
residues were used instead of alanine residues to limit the propensity of the mutated segment to fold 
into a continuous α-helix. The design of the C2Lact and PHFAPP constructs and the expression system 
have been previously described (
18,41
). All the mutations or deletions were checked by DNA 
sequencing.  
GST-Osh6p and mutants were expressed in E. coli (BL21-Gold(DE3) competent cells, 
Stratagene) at 30°C overnight whereas the GST-PHFAPP and GST-C2Lact were expressed at 37°C for 3 h 
upon induction with 1 mM IPTG (when the optical density (OD) of the bacterial suspension, measured 
at 600 nm, reached a value of 0.6). All purification steps were conducted in a buffer with 50 mM Tris, 
pH 7.4, 120 mM NaCl, 2 mM DTT, supplemented during the first purification steps with 1 mM 
PMSF, 1 µM bestatine, 10 µM pepstatine, 10 µM  phosphoramidon and protease inhibitor tablets 
(Roche). Cells were lysed by a French press and the lysate was centrifuged at 200,000 × g for 1 h. The 
supernatant was applied to Glutathione Sepharose 4B beads. After 3 washing steps, the beads were 
incubated with thrombin at 4°C overnight to cleave off the GST tag and release the protein. Afterward, 
they were purified by gel filtration on a Sephacryl S300 HR XK16-70 column. All constructs contain 
an N-terminal GS sequence from the thrombin cleavage site. 
For NBD labeling of Osh6p, PHFAPP or C2Lact, the crude eluate obtained after thrombine 
treatment was concentrated and mixed (after DTT removal by gel filtration on illustra NAP-10 
columns (GE Healthcare)) with a 10-fold excess of N,N’-dimethyl-N-(iodoacetyl)-N’-(7-nitrobenz-2-
oxa-1,3-diazol-4-yl)ethylenediamine (IANBD-amide, Molecular Probes). After 90 min on ice, the 
reaction was stopped by adding a 10-fold excess of L-cysteine over the probe. The free probe was 
removed by gel filtration on a Sephacryl S200 HR XK16-70 column.  The labeled protein was 
analyzed by SDS-PAGE and UV-visible spectroscopy. The gel was directly visualized in a 
fluorescence imaging system (FUSION FX fluorescence imaging system) to detect NBD-labeled 
protein excited in near-UV and then stained with Sypro Orange to determine the purity of NBD-
 labeled protein. The labeling yield (≈ 100%) was estimated from the ratio of the OD of tyrosine and 
tryptophan at 280 nm (=29,450 M-1.cm-1 for PHFAPP, =45,045 M
-1
.cm
-1
 for C2Lact,) and NBD at 495 
nm (=25,000 M-1.cm-1). For all purified proteins, the concentration was determined by a BCA assay, 
by SDS-PAGE analysis using a BSA standard curve and UV spectrometry.  
 
Liposomes preparation 
DOPC (1,2-dioleoyl-sn-glycero-3-phosphocholine), POPC (1-palmitoyl-2-oleoyl-sn-glycero-
3-phosphocholine), diphytanoyl-PC (1,2-diphytanoyl-sn-glycero-3-phosphocholine ), diC12:0-PS 
(1,2-dilauroyl-sn-glycero-3-phospho-L-serine), POPS (1-palmitoyl-2-oleoyl-sn-glycero-3-
phosphoserine), diphytanoyl-PS (1,2-diphytanoyl-sn-glycero-3-phospho-L-serine), POPA (1-
palmitoyl-2-oleoyl-sn-glycero-3-phosphate), liver PI (L-α-phosphatidylinositol), NBD-PE (1,2-
dioleoyl-sn-glycero-3-phosphoethanolamine-N-(7-nitro-2-1,3-benzoxadiazol-4-yl)), Rhod-PE (1,2-
dipalmitoyl-sn-glycero-3-phosphoethanolamine-N-(lissamine rhodamine B sulfonyl)) were purchased 
from Avanti Polar Lipids. diC16:0-PI4P (1,2-dipalmitoyl-sn-glycero-3-phosphoinositol-4-phosphate) 
was from Echelon Lipids Inc.  
Lipids in stock solutions in CHCl3 were mixed at the desired molar ratio. The solvent was 
removed in a rotary evaporator. For lipid films doped with diC16:0-PI4P the mix was pre-warmed to 
33°C for 5 min prior to drying under vacuum. The films were then hydrated in 50 mM HEPES, pH 
7.2, 120 mM K-acetate (HK buffer) to obtain a suspension of multilamellar liposomes. After five 
thawing-freezing cycles, the suspensions were extruded through polycarbonate filters of 0.2 µm pore 
size using a mini-extruder (Avanti Polar Lipids). Mean hydrodynamic radius and polydispersity of 
liposomes were determined by dynamic light scattering at 25°C using a Dynapro apparatus (Protein 
Solutions). Each sample of extruded liposomes was diluted at 50 µM in HK buffer in a 20 µL quartz 
cell. A set of 12 autocorrelation curves was acquired and analyzed using a regularization algorithm. 
Representative mean radius and polydispersity of liposomes, used in this study, according to their lipid 
composition, are listed in the Supplementary Table 2. Liposomes were stored at 4°C and in the dark 
when containing fluorescent lipids and used within 2 days.  
 
Flotation experiments 
The protocol has been described in detail 
53
. Briefly, wild-type Osh6p or each mutant (0.75 µM) was 
mixed with NBD-PE containing liposomes (750 µM total lipids) in 150 µL of HK buffer at 25°C for 
10 min under agitation. The suspension was adjusted to 28% (w/w) sucrose by mixing 100 µL of 60% 
(w/w) sucrose solution in HK buffer and overlaid with 200 µL of HK buffer containing 24% (w/w) 
sucrose and 50 µL of sucrose-free HK. The sample was centrifuged at 240,000 × g in a swing rotor 
(TLS 55) for 1 h. The bottom (250 µL), middle (150 µL) and top (100 µL) fractions were collected. 
The bottom and top fractions were analyzed by SDS-PAGE using Sypro-Orange staining and a 
FUSION FX fluorescence imaging system. 
  
PS and PI4P extraction assay 
Measurements were done in a 96-well black plate using a TECAN M1000 Pro. For PS extraction 
assays, DOPC liposomes (80 µM total lipids) doped with 2% POPS (0.8 µM accessible concentration) 
were mixed with NBD-C2Lact (250 nM) at 25°C in the presence or absence of 3 µM Osh6p or mutants 
in individual well (100 µL final volume). NBD spectra were recorded from 505 to 650 nm (bandwidth 
5 nm) upon excitation at 490 nm (bandwidth 5 nm). The contribution of buffer or liposomes alone was 
subtracted from the NBD signal. A control spectrum was measured with the NBD-C2Lact mixed with 
DOPC liposomes devoid of PS. The intensity at 530 nm measured with PS-containing liposomes in the 
presence or absence of the protein corresponds to Fmax and F, respectively, whereas the intensity 
measured at the same wavelength with pure DOPC liposomes corresponds to F0. The percentage of PS 
extraction is given by using the formula 100×(1-((F-F0)/(Fmax-F0))).  
For PI4P extraction assays, liposomes doped with 2% diC16:0-PI4P were prepared and 
measurements were done with NBD-PHFAPP probe. Liposome and protein concentration were identical 
to those used in the PS extraction assays. Control experiments and determination of extraction 
percentage were performed similarly.   
 
CPM accessibility assay 
A stock solution of CPM (7-Diethylamino-3-(4-maleimidophenyl)-4-methylcoumarin, Sigma-Aldrich) 
at 4 mg/mL was prepared as in 
54
 by mixing 1 mg of CPM powder in 250 µL of DMSO. Thereafter, 
this solution was diluted in a final volume of 10 mL of HK buffer and incubated for 5 min at room 
temperature. The solution was protected from light and used immediately. Osh6p noC/S190C or its 
L69D counterpart (400 nM) was mixed at 30°C with liposomes of various composition (400 µM total 
lipids) in 200 µL of HK buffer. A small volume of the CPM stock solution was added to obtain a final 
concentration of 4 µM. Emission fluorescence spectra were measured from 400 to 550 nm (bandwidth 
5 nm) upon excitation at 387 nm (bandwidth 5 nm) in a 96-well plate using a TECAN M1000 Pro. The 
intensity value at 450 nm corresponds to the spectral peak. Control spectra were recorded in the 
absence of protein. 
 
NBD-based membrane binding assay 
NBD-labeled Osh6p WT or 35 (200 nM) was incubated with liposomes of various composition (400 
µM total lipid) in HK buffer for 10 min at 25°C. Emission fluorescence spectra were recorded from 
500 to 650 nm (bandwidth 5 nm) upon excitation at 460 nm (bandwidth 5 nm) in a 96-well plate using 
a TECAN M1000 Pro. Control spectra were measured in the absence of protein to subtract light 
scattering from liposomes.  
 
  
Real-time membrane dissociation assays 
NBD-labeled Osh6p WT or 35 (100 nM) was mixed with DOPC/diphytanoyl-PS liposomes (70/30 
mol/mol, 400 µM lipid concentration) at 30°C in a cuvette under constant stirring in HK buffer. Then, 
1 µL of a stock solution of diC12:0-PS in methanol (12 mM) was injected to obtain a final 
concentration of 20 µM. Emission fluorescence over time was measured at 540 nm (bandwidth 5 nm) 
upon excitation at 460 nm (bandwidth 5 nm). A control measurement was done by injecting methanol 
alone. As a comparison, the experiment was repeated with NBD-C2Lact (250 nM) incubated with 
liposomes. These experiments were performed with a Shimadzu RF 5301-PC spectrofluorometer.  
 
PI4P transport assay
 
This assay was carried out in a Shimadzu RF 5301-PC spectrofluorometer. The sample (volume 600 
µL) was placed in a cylindrical quartz cell, continuously stirred with a small magnetic bar and 
thermostated at 30°C. At the indicated time, samples were injected from stock solutions with Hamilton 
syringes through a guide in the cover of the fluorimeter. A time zero, a suspension (570 µL) of LB 
liposome (200 µM total lipids, final concentration) containing 2% Rhod-PE and 5% PI4P was mixed 
with 250 nM NBD-PHFAPP in HK buffer. The volume concentration of accessible PI4P (in the outer 
leaflet) was 5 µM. After 2 min, 30 µL of a suspension of LA liposomes (200 µM lipids), incorporating 
5% POPS, were injected. After two additional minutes, Osh6p (200 nM) was injected. PI4P transport 
was followed by measuring the NBD signal at 530 nm (bandwidth 10 nm) upon excitation at 460 nm 
(bandwidth 1.5 nm). This signal reflects the repartition of NBD-PHFAPP between LB and LA liposomes. 
The amount of PI4P transported by Osh6p can be determined by a normalization of the NBD signal 
through the following procedure. First we measured the NBD signal (Fmax) corresponding to a situation 
where PI4P is fully transferred to LA liposomes. NBD-PHFAPP (250 nM) was mixed with LA and LB 
liposomes (200 µM total lipid each) with a lipid composition similar to that of the liposomes used in 
the transport assay, except that LA liposomes initially contained 5% PI4P whereas LB liposomes were 
devoid of PI4P. The fraction (FNorm) of PI4P in LA liposomes, PI4PA/PI4PT, is directly equal to the 
fraction of PHFAPP bound to LA liposomes and is calculated by considering FNorm= (F-F0/Fmax-F0) with 
F0 corresponding to the NBD signal prior to the addition of Osh protein. The amount of PI4P (in µM) 
transferred from LB to LA liposomes corresponds to 5×FNorm. The initial transport rates were 
determined from normalized curves by fitting with a linear function the first eight data points, 
corresponding to a period of 4 s, measured just after Osh6p injection. 
 To examine whether Osh6p or its Δ35 counterpart was bound or not to LA and LB liposomes 
during PI4P transport assays, we performed the same experiments as described above but in the 
absence of NBD-PHFAPP and by injecting the NBD-labeled form of Osh6p and Osh6pΔ35 (200 nM) 
instead of the unlabeled forms. Additional experiments were done with LA and LB liposomes devoid of 
PS and PI4P, respectively. The percentage of Osh6p bound to liposomes corresponds to 100×(F-
Fmin/Fmax-Fmin) with Fmin and Fmax corresponding respectively to the signal of the NBD-labeled Osh6p 
proteins in HK buffer only or in the presence of liposome (400 µM total liposomes) containing 30 
mol% diphytanoyl-PS.  
 
Circular dichroism 
The experiments were performed on a Jasco J-815 spectrometer at room temperature with a quartz cell 
of 0.05 cm path length. Osh6p was dialysed against a buffer with 20 mM Tris, pH 7.4, 120 mM NaF to 
remove glycerol. Each spectrum is the average of several scans recorded from 185 to 260 nm with a 
bandwidth of 1 nm, a step size of 0.5 nm and a scan speed of 50 nm.min
-1
. A control spectrum of 
buffer was subtracted from each protein spectrum. The spectra were analyzed in the 185-240 nm range 
using the SELCON3 method provided on-line by the DICROWEB server 
55
. 
 
Yeast Strains and plasmids and manipulations 
Yeast manipulations were done using standard methods and growth conditions. Strain Osh6-GFP, with 
the genotype MATa his3Δ leu2Δ0 met15Δ0 ura3Δ0 OSH6-GFP::HIS3MX6, was from the GFP collection 56 
supplied by S Léon. All other strains were in the BY4741 background, except for the osh1-7 osh4-
1
ts
 strain : strains osh6 osh7 and cho1Δosh6 Δosh7Δ were a gift from AC Gavin, with genotypes 
MATa can1Δ::STE2pr-LEU2 lyp1Δ his3Δ leu2Δ0 met15Δ0 ura3Δ0 osh6Δ::HYGMX osh7Δ::NATMX, and 
MATa can1Δ::STE2pr-LEU2 lyp1Δ his3Δ leu2Δ0 met15Δ0 ura3Δ0 cho1Δ::KANMX osh6Δ::HYGMX 
osh7Δ::NATMX (
15
). The osh1-7 osh4-1ts strain, CBY926, which is in the SEY6210 background, 
with the genotype MAT ura3-52 leu2-3,112 his3200 trp1-901 lys2-801 suc29 osh1::KANMX 
osh2::KANMX osh3::LYS2 osh4::HIS3 osh5::LEU2 osh6::LEU2 osh7::HIS3 posh4-1ts TRP1 CEN, 
was a gift from C. Beh, supplied by CL Jackson 
42
. Yeast plasmids used in this study are listed in 
Supplementary Table 3. The plasmid pRS315-Osh6-mCherry was a gift from AC Gavin, the Sec63-
sGFP plasmid was obtained from Addgene (#8854) and the plasmid pRS416-C2Lact-GFP was from 
Haematologic technologies. Plasmid pRS315-Osh6-GFP was generated by replacing mCherry with 
PCR-amplified GFP coding sequence. Plasmids expressing N-terminal truncations of Osh6p were 
generated by PCR amplification of the corresponding OSH6 fragments and ligation into the pRS315-
Osh6-mCherry plasmid digested SpeI-BamHI. Osh6p-expressing plasmids with the URA3 marker (for 
growth complementation assay in the osh1-7 osh4-1ts strain) were generated by swapping LEU2 
with the URA3 marker in the pOsh6-mCherry plasmids. The plasmid pOsh6(5A2G)-U was generated 
 by PCR-amplification of the Osh6p(5A2G) coding sequence from the bacterial expression plasmid, 
and ligation into pOsh6-mCherry-U digested by SpeI and BamHI. The plasmid pC2Lact-GFP-L was 
generated by swapping URA3 with the LEU2 marker in pC2Lact-GFP. All plasmid sequences were 
verified by sequencing.  
Yeast growth assay 
The osh1-7 osh4-1ts strain was transformed with the indicated Osh6-mCherry-URA plasmid and the 
resulting transformants were grown overnight in SC without uracil and tryptophan liquid cultures to 
stationary phase. They were spotted in 10-fold serial dilutions onto synthetic media plates without 
uracil and tryptophan and the plates were incubated for 3 – 4 days at 25C and at 37C. 
 
Fluorescent microscopy 
Yeast strains were grown overnight at 30°C in appropriate SD medium to maintain plasmid 
selection. For strains carrying the cho1Δ mutation, SD medium was supplemented with 1 mM 
ethanolamine. Cells were harvested in mid-logarithmic phase (OD600=0.6–0.8) and prepared for 
viewing on glass slides when assessing protein localization at steady state, or in a microfluidics 
chamber in the case of time-course experiments using lyso-PS (see below).  
The cellular localization of PS was monitored in cho1Δ osh6 osh7 strains after the addition 
of exogenous 18:1 lyso-PS (1-oleoyl-2-hydroxy-sn-glycero-3-phospho-L-serine, Avanti Polar Lipids) 
as was previously described 
18
. For lyso-PS time course experiments, cells were injected into a YO4C 
microfluidics chamber using the Microfluidic Perfusion Platform (ONIX), driven by the interface 
software ONIX-FG-SW (CellASIC Corp.). Cells were trapped and maintained in a uniform focal 
plane. Normal growth conditions were maintained by flowing cells with SD medium or SD medium 
containing lyso-PS at 3 psi. The microfluidics device was coupled to a DMI6000 (Leica) microscope, 
equipped with an oil immersion plan apochromat 100x objective NA 1.4, a sCMOS PRIME 95 
(Photometrics), and a spinning-disk confocal system CSU22 (Yokogawa). GFP-tagged proteins and 
mCherry-tagged proteins were visualized with a GFP Filter 535AF45, and RFP Filter 590DF35, 
respectively. Images were acquired with MetaMorph 7 software (Molecular Devices). For the lyso-PS 
time-course assays, we imaged cells every 2 min over a total time of 30 – 40 min, starting with the 
time when lyso-PS-containing medium was injected into the system. We always imaged cells in 5 z-
sections separated by 0.7 µm, afterwards manually selecting for the best focal plane, in order to correct 
for any focal drift during the experiment. Usually we imaged cells in four different fields of 512 × 512 
pixels. Images were processed with ImageJ (NIH) and with Canvas Draw (canvas X) for levels. 
 
Molecular dynamics simulations 
 All MD simulations were performed using the CHARMM36 force field (
57,58
) and the GROMACS 5.0 
MD simulation engine
59
. Bonds involving hydrogen atoms were constrained using the LINCS 
algorithm 
60
 and the integration time step was set to 2 fs. The Nose-Hoover thermostat
61
 was used to 
keep a temperature at 303°K with a coupling time constant of 1 ps in order to preserve the fluidity of 
the membrane. For simulations with constant pressure, the Parrinello-Rahman barostat
62
 was used to 
maintain a pressure of 1 bar with a compressibility of 4.5×10
-5
 and a coupling time constant of 5 ps. 
The cell box size was allowed to vary semi-isotropically (X=Y but not Z) in all membrane simulations 
whereas an isotropic pressure coupling was used in the simulation with the protein only. Van der 
Waals (VDW) interactions were switched to zero over 10 to 12 Å and electrostatic interactions were 
evaluated using the Particle Mesh Ewald 
63
. A bilayer of 1,000 lipids with a binary mix of DOPC and 
POPS (70 and 30%, respectively) was assembled using the CHARMM-GUI membrane builder
64,65
 and 
the CHARMM36 lipid force field 
58
. Both leaflets of the membrane were solvated with a 10 nm layer 
of TIP3P water containing sodium counterions (300 in total considering the two layers)  
66
. The final 
cell box contains 745,971 atoms and its dimensions were ~ 18.1 × 18.1 × 22.4 nm. The box was 
relaxed and equilibrated for 50 ns using the equilibration procedure
65
 designed for the CHARMM-GUI 
and using the GROMACS simulation engine. X-ray structure of Osh6p (PDB entry: 4B2Z
15
; since the 
1-35 residues are not solved in that structure, this latter was named Osh6p35 in the text), 
encapsulating a POPS molecule, was placed in one water layer, with a given orientation, at least 50 Å 
away from the membrane surface, using Pymol (The PyMOL Molecular Graphics System, Version 1.8 
Schrödinger, LLC.) TIP3P molecules and salt ions that overlap spatially with the protein structure or 
were close (within 5 Å in distance) were removed.  The system was thereafter minimized with 
GROMACS and equilibrated with 120 mM NaCl using the CHARMM-GUI procedure. Four distinct 
protein-membrane systems (approximatively 737,820 atoms), in which Osh6p 35 has a distinct 
orientation with respect to the membrane surface, were built, in order to launch four independent 500 
ns trajectories (35-1 to 4). Four systems were also built with Osh6p69 structure (~737,350 atoms), 
which was obtained by deleting the 35-69 region and the POPS molecule from the structure of 
Osh6p35 and after an equilibration by MD for 40 ns in water. Corresponding trajectories are called 
69-1 to 4. 
 
MD analysis 
Classical data analysis Root Mean Square Deviation (RMSD), Root Mean Square Fluctuation 
(RMSF), and secondary structure analysis were done using GROMACS 5 
59
 utilities.  All molecular 
pictures and movies were made with Pymol (http://pymol.org/) 
67
 and Visual Molecular Dynamics 
(VMD) 
68
 softwares. Several non-standard analyses were performed to analyze the interaction between 
Osh6p and the lipid membrane using scripts based on Python language and dedicated functions in the 
MDAnalysis package 
69
. Distance and angle measurements were carried out on the different MD 
 trajectories every 100 ps, resulting in 5,000 data values for each parameter and each MD run. For each 
frame, we calculated and stored the height of Osh6p relative to the membrane, considering the center 
of mass (COM) of the protein (Osh6pΔ35 or Osh6pΔ69) and the z plane of the membrane (z average 
value of the nitrogen atoms (named N) of upper lipids).  For calculating the height of the entry of the 
lipid-pocket relative to the z plane of the membrane, we determined a mass center considering the 
N129, F185 and S190 residues of Osh6p. To calculate the orientation of the protein relative to the 
membrane, we computed the angle between the 346-356 segment of the α7 helix and the plane of the 
lipid patch. We also determined the percentage of time Osh6p’s residues were in contact with the 
membrane, by calculating the z distance between the center of mass of each residue and the z plane of 
membrane (Natoms). For each frame, if the distance was less than a threshold value of 5 Å, we 
counted it as a contact and added it in the residues matrix. The percentage of contact was calculated 
for each residue by dividing the number of positive count by the total number of frames. Electrostatic 
and VDW energies interaction were computed between accessible and solvent-exposed residues of 
Osh6p and lipids using the rerun GROMACS tool.  
Structural analysis 
Accessible Surface Area (ASA) was evaluated on Osh6p’s structures with the program NACCESS 70 
using a probe radius of 1.5 Å. The electrostatic surfaces of Osh6pΔ35 and all mutants were calculated 
with the APBS (Adaptive Poisson-Boltzmann Solver) plugin of PyMOL software
67
. 
 
Sequence alignment  
A first complete set of protein sequences belonging to the Oxysterol Binding Protein family was 
retrieved either from the Pfam (PF01237) or Interpro (IPR000648) database, considering eukaryotic 
species only
71,72
. Fragments coming from incomplete genome assembly were ignored and protein 
sequences that do not contain the EQTSHHPP signature motif (Prosite pattern PS01013) of the 
ORP/Osh family were rejected
73
. In the case of hypothetical splicing variants, only the full-length 
coding sequence was considered for the analysis. Furthermore, redundancy amongst the sequences 
was eliminated by checking available annotations and genomic data. This procedure allowed 
generating a set of 462 sequences belonging to 83 eukaryotic species. A first multiple sequence 
alignment with ClustalO
73
 was done and  sequences that contained the LPTFILE pattern, i.e the PS-
recognizing motif initially identified in the lid of Osh6p
15
, were selected. Then, a second alignment 
was performed (2 iterations, without mbed-like clustering) using this subset, which contains 111 
sequences belonging to 73 species. Alignments were subsequently analyzed with Jalview
74
. Amino-
acid evolution rate was calculated using Consurf upon 4PH7_A PDB structure by maximum 
likelihood model -LG Matrix
75
. Consurf results are displayed with Pymol software
67
. 
 
Data Availability 
  
Data supporting the findings of this manuscript are available from the corresponding author upon 
reasonable request.  A reporting summary for this Article is available as a Supplementary Information 
file.  
 
The source data underlying Figs. 1d-f, 2, 3a, 3c-f, 4, 5,6b, 6d, 7a-b, 7d, 8c-f and Supplementary Figure 
2, 3b-c, 4, 5, 6b-c, 8, 9c-d are provided as a Source Data file. 
 
The raw data that support the findings of this study are available in FigShare with the identifier 
10.6084/m9.figshare.8217824.  
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 Figures legends 
 
Figure 1 Osh6p weakly binds to membranes due to its lid region 
(a) Localization of chromosomally-tagged Osh6p-GFP in wild-type yeast, as depicted in the 
scheme.Brightfield (BF) and GFP fluorescence images are shown. Scale bar: 5 m. 
(b) Localization of Osh6p-GFP, under control of ADH1 promotor expressed from a low-copy plasmid 
in osh6osh7 cells, as depicted in the scheme. Level of Osh6-GFP expression varies due to 
variability in plasmid copy number per cell. Scale bar: 5 m. 
(c) Representation of the different sub-regions of Osh6p showing the position of mutations and 
deletions in Osh6p mutants.  
(d) Localization of Osh6p WT and mutants fused to mCherry expressed from a plasmid in 
osh6osh7 cells as in (b). Scale bar: 5 m. 
(e) Flotation assays. Osh6p (750 nM) was incubated in HK buffer at 25°C for 10 min with DOPC 
liposomes (750 µM lipids) containing 0, 5, 10 or 30% POPS at the expense of DOPC. After 
centrifugation, the liposomes were recovered at the top of a sucrose cushion and analyzed by SDS-
PAGE. The amount of protein recovered in the top fraction (lane 1 to 4) was quantified and the 
fraction of liposome-bound Osh6p was determined using the content of lane 5 (100%) as a reference. 
Experiments were repeated (n=4-7) using different batches of extruded liposomes. 
(f) Osh6p, Osh6p69, Osh6p(L69D) or Osh6p(HH/AA) was added to DOPC liposomes doped with 
30% POPS or to DOPC/POPS/diC16:0-PI4P (66/30/4 mol/mol) liposomes (n=4, *P < 0.05, Mann–
Whitney test). 
(g) Percentage of membrane-bound Osh6p, Osh6pΔ69 or Osh6p(L69D) as a function of the density of 
POPS in liposomes (n=4-7 for Osh6p WT; n=5-6 for Osh6pΔ69; n=5-7 for Osh6p(L69D)). Error bars 
correspond to s.e.m. Source data are provided as a Source Data file.   
 
Figure 2 Osh6p mutants extract differently PS and PI4P  
 (a) PS extraction assay. Fluorescence spectra of NBD-C2Lact (250 nM) measured upon excitation at 
460 nm in the presence of liposomes (80 µM, 2% POPS) before (black spectrum) and after (pink 
spectrum) adding Osh6p or mutants (3 µM). A reference spectrum (in grey) was recorded with pure 
DOPC liposomes incubated with NBD-C2Lact. (b) Percentage of accessible PS extracted by each 
construct based on signal normalization at 536 nm. (n=5-6, **P < 0.01, Mann–Whitney test). 
(c) PI4P extraction assay. Fluorescence spectra of NBD-PHFAPP (250 nM) (λex=460 nm) mixed with 
liposomes (80 µM, 2% diC16:0-PI4P) before (black spectrum) and after (orange spectrum) adding 3 
µM Osh6p WT or mutants. A reference spectrum of NBD-PHFAPP (in grey) was recorded with PI4P-
free liposomes.  
 (d) Percentage of accessible PI4P extracted by each construct based on signal normalization at 536 nm 
(n=4 ,*P < 0.05, Mann–Whitney test). Error bars correspond to s.e.m. Source data are provided as a 
Source Data file. 
 
Figure 3 The binding of Osh6p to anionic lipids depends on its conformational state 
(a) Accessibility CPM assay. Osh6p(noC/S90C) has a unique cysteine which is solvent-accessible 
only if the lid is open. Osh6p(noC/S90C) or its L69D counterpart (400 nM) was incubated in HK 
buffer at 30°C with DOPC liposomes (400 µM lipids) including or not 2% POPS or diC16:0-PI4P. 
CPM (4 µM) was added and the apparition of fluorescence was measured over time. Bars correspond 
to the fluorescence (measured at =470 nm) 30 minutes after adding CPM (n=3).  
(b) Chemical structure of POPS and diphytanoyl-PS.  
(c) PS extraction assay. Fluorescence spectra of NBD-C2Lact (250 nM) (λex=460 nm) mixed with 
DOPC liposomes (80 µM lipid) incorporating 2% POPS or 2% diphytanoyl-PS were recorded before 
and after adding Osh6p (3 µM). A control experiment was done with pure DOPC liposomes. 
Normalized signal provides the fraction (in percentage) of extracted PS (n=4 with POPS; n=3 with 
diphytanoyl-PS). 
(d) Accessibility assay. Osh6p noC/S90C (400 nM) was incubated with DOPC liposomes doped or not 
with 2% POPS or diphytanoyl-PS and mixed with CPM (4 µM). Intensity bars correspond to the 
fluorescence measured 30 min after adding CPM (n=3). 
(e)  Flotation assays. Osh6p (750 nM) was incubated with pure DOPC liposomes (750 µM lipids) or 
liposomes containing 30% POPS, diphytanoyl-PC or diphytanoyl-PS at the expense of DOPC. The 
bars represent the fraction of protein bound to each type of liposomes (n=3-4).  
(f) Emission spectra of NBD-labeled Osh6p (200 nM, excitation at 460 nm) in HK buffer measured in 
the absence (red spectrum) or presence of liposomes (400 µM total lipids) made only of DOPC or 
including 30% POPS, diphytanoyl-PC or diphytanoyl-PS (at the expense of DOPC). The contribution 
of buffer alone or of light scattering from liposomes to the fluorescence signal was subtracted. Error 
bars correspond to s.e.m. Source data are provided as a Source Data file.  
 
Figure 4 Osh6p dissociates from anionic membranes when it extracts a lipid ligand  
(a) PS and PI4P extraction assay. Percentage of accessible PS or PI4P extracted by 3 µM Osh6pΔ35 
and Osh6pΔ35(L69D) from liposomes (80 µM lipids, with 2% POPS or diC16:0-PI4P) using NBD-
C2Lact or NBD-PHFAPP , respectively. Values are obtained by normalizing the signal at 536 nm (n=5-6 
for PS extraction assays, n=4 for PI4P extraction assays. **P < 0.01, *P < 0.05 Mann–Whitney test). 
(b) Flotation assays. Osh6p, Osh6p35, Osh6p69 or Osh6p(L69D) (750 nM) was added to liposomes 
(750 µM lipids) with 70 mol% DOPC and 30 mol% POPS (n=3-4).  
 (c) Binding ability of NBD-labeled wild-type Osh6p (black bar) or 35 mutant (grey bar) to 
liposomes, as function of their composition, was given by the ratio of the NBD fluorescence intensity, 
 F and F0, measured at 536 nm in the presence or absence of liposomes, respectively (n=4, *P < 0.05 
Mann–Whitney test).  
(d) Dissociation of NBD-labeled Osh6p WT or 35 from anionic liposomes (DOPC/diphytanoyl-PS 
7/3 mol/mol) upon adding extractable PS. Each protein (100 nM) was pre-mixed with liposomes (400 
µM lipids) in HK buffer at 30°C. Then, a small volume (1 µL) of a stock solution of diC12:0-PS in 
methanol or of pure methanol was injected. NBD fluorescence was followed at 535 nm (ex=460 nm) 
over 10 min and normalized. Each trace is representative of several experiments. Control 
measurements were performed with NBD-C2Lact (250 nm) instead of NBD-labeled Osh6p. 
(e) Flotation assays. Osh6p, Osh6pΔ35, Osh6p(L69D) or Osh6p35(L69D) at 750 nM was incubated 
with DOPC/diphytanoyl-PS (7/3 mol/mol) liposomes (750 µM lipids) containing increasing amount of 
POPS (0, 2, 5 or 10%). Alternatively, each protein was incubated with DOPC/diphytanoyl-PS (7/3 
mol/mol) membranes with 0, 2, 5 or 10% diC16:0-PI4P (n=4, *P < 0.05, Mann–Whitney test, 
comparison with the data measured with no PS or PI4P). Error bars correspond to s.e.m. Source data 
are provided as a Source Data file. 
 
Figure 5 Osh6p remains mostly soluble during PS/PI4P exchanges between anionic membranes  
(a) PI4P transport assay. LB liposomes (200 µM total lipids), consisting of DOPC, diphytanoyl-PC, 
diC16:0-PI4P and Rhod-PE (68/25/5/2 mol/mol) or DOPC, diphytanoyl-PS, diC16:0-PI4P and Rhod-
PE (68/25/5/2 mol/mol) were incubated with NBD-PHFAPP (250 nM) in HK buffer at 30°C. Then 
DOPC liposomes (200 µM lipids, LA) doped with 5% POPS were added. After 2 min, Osh6p, 
Osh6p35 or Osh6p69 (200 nM) was injected. The dequenching of the NBD signal mirrors the 
translocation of NBD-PHFAPP from LB to LA liposomes due to the transport of PI4P. The signal is 
normalized in term of amount of PI4P delivered into LA liposomes.  
(b) Initial PI4P transport rates of each Osh6p construct measured with LB liposomes containing 
diphytanoyl-PC (orange bar) or –PS (brown bar). The rates, represented as mean (n = 4-9), were 
determined from experiments as shown in (a).  
(c) Time evolution of the binding of NBD-labeled wild-type Osh6p or its 35 counterpart to LA and 
LB liposomes. Liposomes LA, incorporating or not 5% POPS were added to liposomes LB, comprising 
25% of either diphytanoyl-PS or -PC, doped or not with 4% diC16:0-PI4P, in HK buffer at 30°C. 
Then, NBD-Osh6p WT or 35 was added (200 nM). The fluorescence was followed at 535 nm 
(ex=460 nm) over 20 min and normalized. Each trace is representative of several experiments. The 
dashed line corresponds to the NBD signal measured from the protein in buffer alone and which 
corresponds to zero after normalization. Error bars correspond to s.e.m. Source data are provided as a 
Source Data file. 
 
Figure 6 The lid of Osh6p prevents the protein from binding to PS-rich membranes 
 (a) Electrostatic features of the molecular surface of Osh6pΔ35 and Osh6pΔ69.(b) Co-evolution of the 
height and orientation of the protein relative to the membrane surface during each trajectory. The 
height is calculated between the mass center of Osh6pΔ35 (residue 35-434; trace 35-1 to-4) or 
Osh6pΔ69 (residue 70-432, trace 69-1 to 4) and the plane of the DOPC/POPS bilayer during each 
500 ns simulation. The orientation is given by the angle between the 346-356 segment of the 7 helix 
and the plane of the membrane. The time evolution is shown with colors going from blue (beginning 
of the MD trajectory) to green (end of the trajectory). Dark circles and triangles correspond to the 
distance and angle values associated to the initial and final configuration (t=500 ns) of each protein, 
respectively. 
(c) Configuration of Osh6pΔ35 and Osh6pΔ69, bound to the surface of the lipid bilayer at 300 ns of 
the 35-1 trajectory and at the end of 69-2 trajectory, respectively. The surface of the protein is 
shown except for residues of the β11-β12, β14-β15 and β17-β18 loops, which are in contact with the 
membrane: the atoms are represented as sphere with carbon in orange, oxygen in red, nitrogen in blue 
and hydrogen in gray. The lid with the D/E-rich motif is drawn in a ribbon mode. The molecule of 
POPS inside the binding cavity of Osh6pΔ35 is represented in a stick mode. Lipids of the membrane 
are shown in blue grey as stick. The walls of the binding site are coloured in green.  
(d) Percentage of time Osh6p’s residues are in close contact with the membrane. The identities of 
loops and others structural elements that insert in the membrane, are indicated. Source data are 
provided as a Source Data file. 
 
Figure 7 Removal of the lid elicits the reorientation of Osh6p on a bilayer surface 
(a) Evolution of the height between the center of mass of the protein relative to the plane of the bilayer 
during 600 ns. (b) Evolution of the angle between the α7 helix and the plane of the membrane during 
the trajectory. (c) Snapshot at time zero and every 100 ns of the trajectory showing the reorientation of 
the protein relative to the lipid bilayer (d) Percentage of time Osh6p’s residues (f values) are in contact 
with membrane during six successive periods (100 ns each) of the trajectory. The loops corresponding 
to residues in contact with membrane are indicated. As a comparison, the f values are indicated for the 
last 100 ns of the Δ69-1 and Δ69-2 trajectory, during which Osh6pΔ69 is membrane-bound. The f 
values of the last 100 ns of Δ69-3 trajectory, similar to those of Δ69-2 trajectory, were omitted for 
clarity. Source data are provided as a Source Data file. 
 
Figure 8 Mutations in the D/E-rich motif impact Osh6p activity  
(a)  Sequence of the D/E-rich motif with the anionic residues colored in red. Substitutions by alanines 
or glycines in the 4A and 5A2G mutant are in bold.(b) Electrostatic features of the surface of Osh6p 
and mutants. (c) Percentage of accessible PS or PI4P extracted by Osh6p, Osh6p-4A or Osh6p-5A2G 
(3 µM) from liposomes (80 µM lipids) with 2% POPS or diC16:0-PI4P (n=3-8, *P < 0.05, **P < 0.01, 
Mann–Whitney test). (d) Flotation assays. Osh6p, Osh6p-4A or Osh6p-5A2G was mixed with 
 DOPC/POPS/diC16:0-PI4P (66/30/4 mol/mol) liposomes (n=3). (e) Initial PI4P transport rates of 
Osh6p and of 4A and 5A2G mutants (200 nM) determined with LB liposomes containing 5% diC16:0-
PI4P and either 25% diphytanoyl-PC (orange bar) or –PS (brown bar) and LA liposomes containing 
5% POPS (n=3-9). (f) Ratio between the initial PI4P transport rate, measured for Osh6p and mutants 
when LA and LB liposomes are weakly anionic (with 5% POPS and 5% PI4P respectively) and the 
transport rate measured with LB liposomes that are more anionic (with 25% of diphytanoyl-PS instead 
of diphytanoyl-PC (as in (e), brown bar, n = 3-9) or the rate measured with LA and LB liposomes that 
are both more anionic, doped respectively with 15% PI and 4% POPA (at the expense of DOPC), and 
10% PI, 4% POPA and 25% diphytanoyl-PS instead of diphytanoyl-PC (purple bars, n=4). (g) Growth 
of osh1-7 yeast, containing a plasmid-borne copy of a temperature-sensitive allele of OSH4 and the 
indicated version of OSH6, at permissive (25C) or non-permissive (37C) temperature for osh4-1ts. 
(h) Redistribution of C2Lact-GFP in PS-depleted yeast cells (cho1osh6osh7) expressing Osh6p-
mCherry or the 5A2G mutant after adding 18:1 lyso-PS. Images were taken every 2 min, with the first 
panel (t = 0*) showing the last time-point before the onset of C2Lact-GFP signal transition. The 
absolute timing of this time-point varied between experiments (15-25 min after lyso-PS injection) due 
to instability of the lyso-PS suspension 
18
. Scale bar: 5 m. Error bars correspond to s.e.m. Source data 
are provided as a Source Data file. 
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Supplementary Figure 1. Cellular localization and PS transport activity of Osh6p wild-type and 
N-terminal mutants  
(a) Colocalization between Osh6p variants (WT, L69D or 69 truncation mutant), fused to mCherry, 
and the ER marker Sec63-GFP in osh6 osh7 cells. Two fields of cells are shown for each strain, 
with left panels showing bright-field (BF) images. (b) Redistribution of the PS reporter C2Lact-GFP in 
PS-depleted yeast cells (cho1 osh6 osh7) expressing Osh6p-mCherry WT, L69D or 69 mutant 
after exogenous addition of 18:1 lyso-PS. Images were taken every 2 min as indicated, with the first 
panel (t = 0*) showing the last time-point before the onset of C2Lact-GFP signal transition. The 
absolute timing of this time-point varied between experiments (between 15 and 25 min after lyso-PS 
injection) due to instability of the lyso-PS suspension 
1
. Scale bar: 5 m.  
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Supplementary Figure 2. Measure of the conformational state of Osh6p with an accessibility 
assay using CPM   
(a) Time evolution of the CPM signal (ex=387 nm) after adding the fluorophore (4 µM) to Osh6p 
noC/S190C or its L69D variant (400 nM) in HK buffer alone or in the presence of liposomes only 
made of DOPC (400 µM total lipids) or containing either 2 mol% POPS or PI4P. Control experiments 
are done without Osh6p protein. (b) Typical emission spectra of Osh6p noC/S190C and its L69D 
counterpart (400 nM) after an incubation of 30 min with 4 µM CPM in the presence of pure DOPC 
liposomes  or liposomes doped with either 2 mol% POPS or PI4P. A control experiment is done 
without Osh6p protein (gray spectrum). (c) Far-UV CD spectrum of Osh6p noC/S190C and its L69D 
variant (10 µM) in 20 mM Tris, pH 7.4, 120 mM NaF buffer. The percentage of α-helix, β-sheet and 
turn, deriving from the analysis of the spectrum are given as well as the values deriving from the 
crystal structure (PDB ID: 4B2Z) using the DSSP algorithm. Source data are provided as a Source 
Data file. 
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Supplementary Figure 3.  Biochemical characterization of the NBD-Osh6p constructs 
(a) Tridimensional model of the NBD-labeled Osh6p35 based on the crystal structure of the protein 
(PDB ID: 4B2Z). Several cysteines (C62, C162 and C389) are mutated into serine; the threonine 262 
in the β14-β15 loop is substituted into a cysteine. An N,N’-dimethyl-N-(acetyl)-N’-(7-nitrobenz-2-
oxa-1,3-diazol-4-yl)ethylenediamine moiety (in stick, with carbon in green, nitrogen in blue and 
oxygen in red), manually built and energetically minimized, is grafted to the thiol function of the C262 
residue. (b) SDS-PAGE of purified NBD-Osh6p WT and 35. The gel was directly visualized in a 
fluorescence imaging system to identify labeled proteins (right picture) and then stained with Sypro 
Orange to visualize the protein and molecular weight markers (left picture). (c) UV-visible absorption 
spectrum of the wild-type Osh6p and the Δ35 mutant labeled with NBD. Considering a purity grade of 
100% for the protein, the analysis of the optical density at 280 nm (Trp) and 495 nm (IANBD) 
indicated that each construct was labeled with the probe in a 1:1 ratio. Source data are provided as a 
Source Data file. 
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Supplementary Figure 4.  Ligand-dependent binding of Osh6p to anionic membranes 
(a) Flotation assay. Osh6p (750 nM) was incubated with DOPC liposomes (750 µM total lipids) 
enriched with 30 mol% of POPS, diphytanoyl-PS, POPA or liver PI (at the expense of DOPC). The 
bars correspond to the mean of three independent experiments. (b) PI4P extraction assay. NBD-PHFAPP 
(250 nM) was incubated with DOPC liposomes (80 µM lipids) containing 2 mol% diC16:0-PI4P or, 
additionally, 10 mol% of POPS, POPA or liver PI. The fluorescence spectra of the probe were 
measured (ex= 460 nm) before and after adding Osh6p WT (3 µM). Reference spectra were recorded 
with liposomes devoid of PI4P. The percentage of extracted PI4P was calculated based on the 
fluorescence signal at 536 nm measured with and without Osh6p and with PI4P-free liposomes (n=4). 
(c) Flotation assay. Osh6p, Osh6p35, Osh6p69 or Osh6p(L69D) (750 nM) was mixed with DOPC 
liposomes (750 µM lipids) doped with 5 mol% of POPS or 30 mol% of POPS and 4 mol% of PI4P 
(n=3). (d) Flotation assay. Osh6p or Osh6pΔ35 (750 nM) was incubated with DOPC/POPA (7/3 
mol/mol) or DOPC/PI (7/3) liposomes (750 µM lipids) containing or not 5 mol% of POPS or diC16:0-
PI4P, at the expense of POPA or PI (n=3).  Error bars correspond to s.e.m. Source data are provided as 
a Source Data file. 
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Supplementary Figure 5. Conservation of an acidic stretch at the N-terminal end of the lid of 
putative PS/ PI4P exchangers 
(a) Sequence alignment of putative PS/PI4P counter-exchangers containing the LPTFILE motif. The 
alignment procedure was performed on a set of 104 eukaryotes sequences from 73 eukaryotes species 
but for clarity, only 35 sequences of representative species are shown. Genera, species, UniprotKB 
accession number and the residue position are given for each sequence. Residues are colored 
according to their physicochemical properties (aliphatic, salmon; aromatic, orange; positively-charged, 
blue ; negatively-charged, red ; hydrophilic, green ;  proline and glycine residues, magenta ; cysteine 
residues, yellow).The sequences are ordered following the evolutionary timeline of species and the 
divergence time is given following molecular clock phylogenetics studies
2
. This phylogenetic analysis 
identifies three distinct subgroups called Osh6p/Osh7p, ORP5/8 and ORP9/10/11 clade, which would 
have evolved independently from an ancestral sequence common to Holomycota and Holozoa one 
billion years ago. A star indicates the most basal lineage of each clade. A Jalview analysis, showing 
consensus and conservation score at the top of the figure, indicates that an acidic motif (consensus 
EDDDTDDTEEVDEE) localized at the N-terminus of the lid is well-conserved in the Osh6p/Osh7p 
clade, in particular in Saccharomycotina (highlighted in grey), and also in ORP9/10/11 clade.  (b) 
Surface of the Osh6p's structure (PDB ID: 4PH7) showing the degree of conservation of amino acids 
in the ORD considering all sequence with the PS-recognizing motif LPTFILE (left) identified in our 
sequence analysis, or only the Saccharomycotina (right). Cyan-to-purple color scale indicates the 
degree of conservation. The acidic track and the lid are represented in ribbon and the anionic residues 
of the D/E–rich motif are shown in a stick mode. Source data are provided as a Source Data file. 
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Supplementary Figure 6. RMSD and RMSF profile for Osh6p35 and Osh6p69 
(a) Configuration of Osh6p35 and Osh6p69 at the beginning of each trajectory. The initial height 
(h) between the mass center of each form of Osh6p relative to the plane of the DOPC/POPS bilayer is 
indicated. The initial angle between the 346-356 segment of the 7 helix and the plane of the 
membrane is also reported. (b) Control plots representing the stability of Osh6pΔ35 (residues 35-432) 
or Osh6pΔ69 structure (residues 70-432) during four independent 500-ns MD run. The root mean 
square deviation (RMSD) of the backbone atoms from the equilibrated conformation (0 ns) is 
presented as a function of time for each trajectory. (c)  Root mean square fluctuation (RMSF) values 
of atomic positions computed for the backbone atoms, indicative of the internal protein motion during 
each MD, are shown as a function of residue number. Source data are provided as a Source Data file. 
10 
 
 
Supplementary Figure 7. Time evolution of the secondary structural elements of Osh6pΔ35 and 
Osh6pΔ69 along each MD simulation.  Osh6pΔ35 (left panel); Osh6pΔ69 (right panel). The x-axis 
represents the MD trajectory time (in ns), while the residue numbers are shown on the y-axis.  
11 
 
Supplementary Figure 8. Evolution of the protein-membrane interaction energy over time for 
each trajectory 
(a) Co-evolution of the height and orientation of the Osh6pΔ35 or 69 structure relative to the 
membrane during each trajectory is represented as in Figure 5. Each point of the trajectory is coloured 
according to a code, ranging from blue to red, which is function of the Coulomb energy (from 0 to -
2,500 kcal.mol
-1
). Green circles and triangles correspond to the height and angle values associated to 
the initial and final configuration (t=500 ns) of each protein, respectively. (b) VDW interaction 
between the protein and the membrane (colour code from light gray to black corresponding to a range 
of value between 0 and -640 kcal mol
-1
). Source data are provided as a Source Data file. 
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Supplementary Figure 9. The lid prevents the lipid-binding pocket from being close to the 
membrane surface 
(a) Configuration of Osh6pΔ35, bound to the surface of the DOPC/POPS (7/3) bilayer at 300 ns (top) 
and at the end of the 35-1 trajectory (bottom). The protein is shown in a cartoon mode and colored in 
light grey. The side chains of the residues of the 14-15 and 17-18 loops are represented in a stick 
mode and colored in dark grey. The contour of the lipid-binding pocket is represented by a transparent 
blue surface whereas the center of the pocket entry is represented by a solid green sphere. Atoms of 
the membrane lipids are shown in a wireframe representation with carbon in light blue, oxygen in red, 
nitrogen in blue, hydrogen in grey and phosphorus in orange. (b) Configuration of Osh6pΔ69, bound 
to the surface of the lipid bilayer at the end of the 69-2 (top) and 69-4 trajectories (bottom). The 
side chains of the residues of the 11-12, 14-15 and 17-18 loops as well as the 7-strand are 
represented in a stick mode and colored in dark grey. (c) Evolution of the height of the pocket entry 
relative to the plane of the bilayer during 500 ns. (d) Difference in accessible surface area (ASA) per 
residue between the Δ35 and Δ69 structures. The position of the residues belonging to the β7-strand, 
the β7-β8 and the β11-β12 loops, which are unmasked in the absence of the 35-69 region, are 
indicated.  (e) The structure of Osh6pΔ35 has been superposed to that of Osh6pΔ69 when bound to the 
membrane at the end of the Δ69-2 (left) and Δ69-4 trajectories (right). This indicates what would be 
the theoretical localisation of the lid and the D/E-rich motif if Osh6pΔ35 adopted such a docking 
geometry on membrane. Likewise, the POPS molecule is represented in a sphere mode to show its 
position relative to the surface of the bilayer surface. Atoms of the membrane lipids are shown in a 
wireframe representation with carbon in light blue, oxygen in red, nitrogen in blue, hydrogen in grey 
and phosphorus in orange. Source data are provided as a Source Data file. 
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Supplementary Table 1. Primers used to delete region or insert mutations in Osh6p  
Deletion/Mutation 
Designation Primer name Sequence 
35 
Osh6_Δ35_For CGTGGATCCATGGGCTCCATTGATACCGACGATATTGA
TGAAGACG 
Osh6_Δ35_Rev CGTCTTCATCAATATCGTCGGTATCAATGGAGCCCATG
GATCCACG 
C62S 
Osh6_C62S_For CAATTGAGACCAGGCAGTGATTTGACCAGGATCACC 
Osh6_C62S_Rev GGTGATCCTGGTCAAATCACTGCCTGGTCTCAATTG 
C162S 
Osh6_C162S_For GTCACCATCCTCCAGAAAGTGCATATTTTTACATG 
Osh6_C162S_Rev CATGTAAAAATATGCACTTTCTGGAGGATGGTGAC 
C389S 
Osh6_C389S_For GGCGAAGATCTTGACTATTCTATTTATAAAAATATCCC 
Osh6_C389S_Rev GGGATATTTTTATAAATAGAATAGTCAAGATCTTCGCC 
S190C 
Osh6_S190C_For GATTTTTAGGTAATTCATGTGCGGCCATGATGGATGG 
Osh6_S190C_Rev CCATCCATCATGGCCGCACATGAATTACCTAAAAATC 
T262C 
Osh6_T262C_For GGATATGTTTTTGGATGTTACGATGCAATCGAAGGG 
Osh6_T262C_Rev CCCTTCGATTGCATCGTAACATCCAAAAACATATCC 
L69D
(a)
 
Osh6_L69D*_For GTGATTTGACCAGGATCACCGATCCTACTTTTATTTTA
GGG 
Osh6_L69D*_Rev CCCTAAAATAAAAGTAGGATCGGTGATCCTGGTCAAAT
CAC 
4A 
Osh6_4A_For GCCAATTGATACCGCCGCTATTGCTGCAGACGATGAAT
CTGG 
Osh6_4A_Rev CCAGATTCATCGTCTGCAGCAATAGCGGCGGTATCAAT
TGGC 
5A2G 
Osh6_5A2G_For CCGCCGCTATTGCTGCAGGCGGTGCATCTGGTCATAAT
ATTATC 
Osh6_5A2G_Rev GATAATATTATGACCAGATGCACCGCCTGCAGCAATAG
CGGCGG 
69 see Moser von Filseck, 2015 
1 
L69D see Moser von Filseck, 2015 1 
H157A/H158A see Moser von Filseck, 2015 1 
(a)
 These oligonucleotides were designed to introduce the L69D substitution in Osh6p(noC/S190C) bearing the 
C62S mutation  
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Supplementary Table 2. Radius vs lipid composition of the main liposomes used in the study 
Lipid composition (mol/mol) 
Hydrodynamic radius (RH, nm) 
batch 1 batch 2  batch 3 batch 4 
DOPC (100) 99.9 ± 28.1 118.8 ± 48.4 114.2 ± 39.5
(N)
 105.7 ± 40.3 
DOPC/POPS (95/5) 82.4 ± 29.8
(N)
 81.4 ± 28.0
(N)
 93.0 ± 32.0
(N)
  
DOPC/POPS (90/10) 85.4 ± 47.4
(N)
 83.0 ± 25.7
(N)
   
DOPC/POPS (70/30) 100.0 ± 27.0 93.0 ± 32.0 96.4 ± 31.0  
DOPC/POPS (50/50) 95.7 ±37.3
(N)
    
POPS (100) 96.9 ± 27.2
(N)
    
DOPC/POPS/diC16:0-PI4P (66/30/4) 92.0 ± 28.5
(N)
    
     
DOPC/POPS (98/2) 108.0  ± 40.3    
DOPC/ diC16:0-PI4P (98/2) 100 ± 21.47    
DOPC/diphytanoyl-PS (98/2) 106.8 ± 44.4 93.6 ± 46.7
(N)
 97.6 ± 45.1  
     
DOPC/diphytanoyl-PS (70/30) 93.6 ± 46.7
(N)
 97.6 ± 45.1
(N)
 89.8 ± 35.9 108.0 ± 44.5 
DOPC/diphytanoyl-PS/POPS 
(70/28/2) 94.6 ± 43.1
(N)
 
   
DOPC/diphytanoyl-PS/POPS 
(70/25/5) 83.3 ± 34.6
(N)
 
   
DOPC/diphytanoyl-PS/POPS 
(70/25/10) 100.4 ± 35.6
(N)
 
   
DOPC/diphytanoyl-PS/ diC16:0-PI4P 
(70/28/2) 99.56 ± 37.8
(N)
 
   
DOPC/diphytanoyl-PS/ diC16:0-PI4P 
(70/25/5) 99.9 ± 34.6
(N)
 
   
DOPC/diphytanoyl-PS/ diC16:0-PI4P 
(70/25/10) 97.7 ± 26.6
(N)
 
   
     
DOPC/diphytanoyl-PC (70/30)  145.0 ± 76.0 107.7 ± 46.5
(N)
   
DOPC/diphytanoyl-PC/diC16:0-PI4P 
(70/25/5)  95.34 ± 39.38 
   
     
DOPC/POPA (70/30)  95.7 ± 27.8
(N)
 97.5 ±40.3
(N)
   
DOPC/POPA/POPS (70/25/5) 98.2 ± 35.2
(N)
    
DOPC/POPA/diC16:0-PI4P (70/25/5) 97.3 ± 41.7
(N)
    
DOPC/PI (70/30) 110.5 ± 45.0
(N)
 97.9 ± 25.7
 (N)
   
DOPC/PI/POPS (70/25/5) 96.1± 39.3
(N)
    
DOPC/PI/diC16:0-PI4P (70/25/5) 116.0 ± 35.6 
(N)
    
     
DOPC/PI/POPA/POPS (76/15/4/5) 98.3  ± 45.0    
DOPC/ diphyt-PS/PI/POPA/ diC16:0-
PI4P (56/25/10/4/5) 98.3  ± 27.8 
(R)
 
   
(N) 
liposomes contain trace amount of NBD-PE (0.3 mol%) 
(R)
 liposomes contain 2 mol% of Rhod-PE at the expense of DOPC  
16 
 
Supplementary Table 3. Yeast plasmids used in this study. 
Name/Alias Description Origin/Reference 
pRS315-Osh6-mCh ADH1pr:OSH6-mCherry, CEN, LEU2 (pRS315-based) Maeda et al, 2013 
3
 
pRS315-Osh6-GFP ADH1pr:OSH6-GFP, CEN, LEU2 (pRS315-based) This study 
pAC89 
pOsh6(L69D) 
ADH1pr:osh6[L69D]-mCherry, CEN, LEU2 (pRS315-based) Moser von Filseck, 
2015 
1
 
pAC91 
pOsh6(HHAA) 
ADH1pr:osh6[H157A,H158A]-mCherry, CEN, LEU2 
(pRS315-based) 
Moser von Filseck, 
2015 
1
 
pAC95 
pOsh669 
ADH1pr:osh6[70-448]-mCherry, CEN, LEU2 (pRS315-
based) 
This study 
pSec63-sGFP SEC63-sGFP, CEN, URA3 (pRS316-based) Prinz et al, 2000 
4
 
pC2Lact-GFP GPDpr:C2Lact-GFP, CEN, URA3 (pRS416-based) Yeung et al, 2008 
5
 
pAC100 
pOsh6-mCh-U 
ADH1pr:OSH6-mCherry, CEN, URA3 (pRS315-based) This study 
pAC101 
pOsh6(L69D)-U 
ADH1pr:osh6[L69D]-mCherry, CEN, URA3 (pRS315-based) This study 
pAC102 
pOsh6(HHAA)-U 
ADH1pr:osh6[H157A,H158A]-mCherry, CEN, URA3 
(pRS315-based) 
This study 
pAC103 
pOsh669-U 
ADH1pr:osh6[70-448]-mCherry, CEN, URA3 (pRS315-
based) 
This study 
pAC104 
pOsh635-U 
ADH1pr:osh6[36-448]-mCherry, CEN, URA3 (pRS315-
based) 
This study 
pAC106 
pOsh6(5A2G)-U 
ADH1pr:osh6[D38A,D39A,D41A,E42A,D43G,D44G,E45A]-
mCherry, CEN, URA3 (pRS315-based) 
This study 
pAC107 
pC2Lact-GFP-L 
GPDpr:C2Lact-GFP, CEN, LEU2 (pRS416-based) This study 
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